+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Medical Device CRO Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Target Therapeutic Area, Scale of Operation, Device Class, Type of Clinical Service Offered, Type of Preclinical Service Offered and Key Geographies- Product Image
Medical Device CRO Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Target Therapeutic Area, Scale of Operation, Device Class, Type of Clinical Service Offered, Type of Preclinical Service Offered and Key Geographies- Product Image
New

Medical Device CRO Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Target Therapeutic Area, Scale of Operation, Device Class, Type of Clinical Service Offered, Type of Preclinical Service Offered and Key Geographies

  • PDF Icon

    Report

  • 560 Pages
  • December 2025
  • Region: Global
  • Roots Analysis
  • ID: 6044659
Description Jump to:
The global medical device CRO market is estimated to grow from USD 13.3 billion in the current year to USD 19.3 billion by 2035, at a notable CAGR during the forecast period, till 2035.

MEDICAL DEVICE CRO MARKET: GROWTH AND TRENDS

The rise in the elderly population and the prevalence of illnesses, especially chronic conditions, has resulted in a growing need for innovative medical devices in various therapeutic fields. Since 2020, approximately 105 medical devices have been approved by the USFDA. Additionally, it is interesting to highlight that more than 35 medical devices obtain FDA approval every year.

Nonetheless, a key challenge encountered by this sector is the lengthy and complicated product development process of a new medical device. The clinical phase is highly resource-demanding, involving increased expenses and elevated risks. Further, the strict regulatory standards to guarantee the security of medical devices complicate the operations for industry leaders.

To circumvent the aforementioned bottleneck, developers of medical devices are increasingly outsourcing their research activities to specialized medical device CROs. These entities provide knowledge in executing clinical studies, managing regulatory demands, and maintaining adherence to safety regulations. By closely collaborating with manufacturers, CROs facilitate the transformation of innovative concepts into market-ready products, while diligently overseeing the entire product development lifecycle.

Moreover, the landscape of medical devices is swiftly evolving, propelled by the incorporation of innovative technologies and tools, such as risk monitoring systems, sophisticated data analytics, real-world evidence solutions, and cloud computing. Due to continuous research and development, along with the growing opportunities related to the medical devices market, it is expected that the medical devices CRO market will experience significant growth in the next ten years.

MEDICAL DEVICE CRO MARKET: KEY INSIGHTS

The report delves into the current state of the medical device CRO market and identifies potential growth opportunities within the industry. Some key findings from the report include:
  • More than 590 CROs currently claim to have the required capabilities to offer a wide range of research and analytical services for medical devices, across different scale of operation.

  • The market is well fragmented, featuring a mix of players based across different geographical regions that provide services for a range of medical device classes.
  • In pursuit of building a competitive edge, medical devices CROs are actively upgrading / expanding their capabilities to enhance their respective portfolios of offerings.

  • Over the years, industry players have undertaken a variety of initiatives to further advance the development / enable the improvement of their proprietary services for medical devices.
  • The rising interest in this domain is reflected in the number of mergers and acquisitions that have been reported in the last few years; 53% of such initiatives were focused on geographical consolidation.
  • Over 14,000 trials, enrolling close to 4.6 million patients suffering from a myriad of disease indications, have been registered across the globe to evaluate the efficacy and accuracy of medical devices.
  • Our proprietary total cost of ownership model suggests an informed estimate of direct and indirect expenses while setting up a contract research facility in different regions over a span of 20 years.

  • Driven by the ongoing efforts of industry stakeholders, the medical devices contract research service providers the market is expected to witness steady growth in the coming decade.

MEDICAL DEVICE CRO MARKET: KEY SEGMENTS

Currently, Clinical Operations Segment Occupies the Largest Share of the Medical Device CRO Market

In terms of the scale of operation, the market is segmented into clinical and preclinical services. At present, the clinical services sector captures the largest share of the medical device CRO market. Notably, the rising number of clinical trials focused on medical devices is expected to propel the market in the short-term.

Class II Devices Segment is the Fastest Growing Segment of the Medical Device CRO Market During the Forecast Period

In terms of the device class, the market is segmented into Class I, Class II, Class III. Currently, class II devices hold maximum share within the medical devices CRO market. This trend is unlikely to change in the short-mid-term.

Currently, Clinical Trial Management Segment Occupies the Largest Share of the Medical Device CRO Market

In terms of the type of clinical services, the market is segmented into clinical trial management, data management, regulatory affairs management, and consulting. Currently, clinical trial management dominates the medical devices CRO market. This pattern is expected to persist in the coming years.

Biocompatibility Testing Services Segment is the Fastest Growing Segment of the Medical Device CRO Market During the Forecast Period

In terms of the type of preclinical services, the market is segmented into biocompatibility testing, sterility, microbiology testing, material characterization, and analytical services. It is worth highlighting that, at present, sterility and microbial testing holds a larger share of the medical device CRO market. This trend is likely to remain the same in the coming decade.

Currently, CNS Disorders Segment Occupies the Largest Share of the Medical Device CRO Market

In terms of therapeutic area, the market is segmented into cardiovascular disorders, CNS disorders, metabolic disorders, oncological disorders, ophthalmological disorders, orthopedic disorders, pain disorders, psychological disorders, respiratory disorders and other disorders. It is worth highlighting that majority of the current medical device CRO market is captured by CNS disorders.

North America Accounts for the Largest Share of the Medical Device CRO Market

In terms of key geographical regions, the market is segmented into North America, Europe, Asia-Pacific and the Rest of the world. Majority share is expected to be captured by CROs based in North America. It is worth highlighting that, over the years, the market of the rest of the world is expected to grow at a higher CAGR.

Example Players in the Medical Device CRO Market

  • Avania
  • Charles River Laboratories
  • CROMSOURCE
  • CSSi LifeSciences
  • Eurofins Medical Testing
  • IQVIA
  • Medpace
  • NAMSA
  • Qserve Group
  • WuXi AppTec

Primary Research Overview

The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders. The research report features detailed transcripts of interviews held with the following industry stakeholders:
  • Chief Executive Officer and Co-founder, Company A
  • Senior Vice President of Business Development and Marketing, Company B
  • Vice President of Global Marketing and Commercial Operations, Company C
  • Head of Business Development, Company D
  • General Manager, Company E
  • Chief Operating Officer, Company F
  • Senior manager, Medical & Clinical Operations, Company G
  • Technical Director and Partner, Company H
  • Director of Business Development, Company I
  • Business Development Manager, Company J

MEDICAL DEVICE CRO MARKET: RESEARCH COVERAGE

  • Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the medical device CRO market, focusing on key market segments, including [A] scale of operation, [B] device class, [C] type of clinical services offered, [D] type of preclinical services offered, [E] therapeutic area and [F] geographical regions.
  • Market Landscape: A comprehensive evaluation of contract research organizations involved in the medical device CRO market, considering various parameters, such as [A] year of establishment, [B] company size (in terms of the number of employees), [C] location of headquarters, [D] area of specialization, [E] device class, [F] types of CRO services offered by [F1] clinical service providers, [F2] preclinical service providers and [F3] stand-alone service providers.
  • Regulatory and Reimbursement Landscape Analysis: A discussion on general regulatory guidelines established and issued by major regulatory bodies for medical device approval. In addition, it includes an insightful multi-dimensional heat map analysis, featuring a comparison of the contemporary regulatory and reimbursement scenarios in key geographies across the globe.
  • Company Profiles: In-depth profiles of key industry players offering CRO services for both clinical and preclinical stage development of medical devices, focusing on [A] company overviews, [B] medical device-focused service portfolio, [C] recent developments and [D] an informed future outlook.
  • Competitive Benchmarking Analysis: A competitive benchmarking analysis that emphasizes the primary focus areas of small, mid-sized, and large companies. This analysis compares their existing capabilities within and beyond their respective peer groups based in North America, Europe, Asia-Pacific, and other regions. It offers stakeholders insights into potential strategies for achieving a competitive edge in the industry.
  • Key Performance Indicators: An analysis highlighting the key performance indicators used by sponsor companies to evaluate service providers engaged in the medical device CRO market, based on information gathered via secondary research (for top-ten medical device players) and primary research.
  • Brand Positioning Analysis: A comprehensive analysis of brand positioning for top industry players, highlighting the prevailing perceptions of their proprietary brands.
  • Clinical Trials Analysis: Examination of completed, ongoing, and planned clinical studies of various medical devices, based on parameters like [A] trial registration year, [B] trial phase, [C] current trial status, [D] enrolled patient population, [E] study design, [F] leading industry players (in terms of number of trials conducted), [G] target therapeutic area(s) and [H] key geographical regions.
  • Merger and Acquisitions: A comprehensive examination of the various mergers and acquisitions, focusing on multiple relevant parameters, including [A] year of agreement, [B] type of agreement and [C] geographical location of the companies.
  • Total Cost of Ownership: An in-depth analysis of the total cost of ownership for a medical device contract research service provider, which includes a well-informed estimate of both direct and indirect costs.
  • Survey Analysis: A survey analysis featuring inputs solicited from various experts who are directly / indirectly involved in providing CRO services to medical device developers.
  • SWOT Analysis: A SWOT analysis, focusing on key drivers and challenges that are likely to impact the industry’s evolution. Further, it includes a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall industry.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How many companies are currently engaged in this market?
  • Which are the leading companies in this market?
  • What factors are likely to influence the evolution of this market?
  • What is the current and future market size?
  • What is the CAGR of this market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

  • The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
  • Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
  • The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

  • Complimentary PPT Insights Packs
  • Complimentary Excel Data Packs for all Analytical Modules in the Report
  • 15% Free Content Customization
  • Detailed Report Walkthrough Session with the Research Team
  • Free Updated report if the report is 6-12 months old or older

Table of Contents

SECTION I: REPORT OVERVIEW
1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.2.1. Market Landscape and Market Trends
2.2.2. Market Forecast and Opportunity Analysis
2.2.3. Comparative Analysis
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Types of Primary Research
2.4.2.1.1. Qualitative Research
2.4.2.1.2. Quantitative Research
2.4.2.1.3. Hybrid Approach
2.4.2.2. Advantages of Primary Research
2.4.2.3. Techniques for Primary Research
2.4.2.3.1. Interviews
2.4.2.3.2. Surveys
2.4.2.3.3. Focus Groups
2.4.2.3.4. Observational Research
2.4.2.3.5. Social Media Interactions
2.4.2.4. Key Opinion Leaders Considered in Primary Research
2.4.2.4.1. Company Executives (CXOs)
2.4.2.4.2. Board of Directors
2.4.2.4.3. Company Presidents and Vice Presidents
2.4.2.4.4. Research and Development Heads
2.4.2.4.5. Technical Experts
2.4.2.4.6. Subject Matter Experts
2.4.2.4.7. Scientists
2.4.2.4.8. Doctors and Other Healthcare Providers
2.4.2.5. Ethics and Integrity
2.4.2.5.1. Research Ethics
2.4.2.5.2. Data Integrity
2.4.3. Analytical Tools and Databases
2.5. Robust Quality Control
3. MARKET DYNAMICS
3.1. Chapter Overview
3.2. Forecast Methodology
3.2.1. Top-down Approach
3.2.2. Bottom-up Approach
3.2.3. Hybrid Approach
3.3. Market Assessment Framework
3.3.1. Total Addressable Market (TAM)
3.3.2. Serviceable Addressable Market (SAM)
3.3.3. Serviceable Obtainable Market (SOM)
3.3.4. Currently Acquired Market (CAM)
3.4. Forecasting Tools and Techniques
3.4.1. Qualitative Forecasting
3.4.2. Correlation
3.4.3. Regression
3.4.4. Extrapolation
3.4.5. Convergence
3.4.6. Sensitivity Analysis
3.4.7. Scenario Planning
3.4.8. Data Visualization
3.4.9. Time Series Analysis
3.4.10. Forecast Error Analysis
3.5. Key Considerations
3.5.1. Demographics
3.5.2. Government Regulations
3.5.3. Reimbursement Scenarios
3.5.4. Market Access
3.5.5. Supply Chain
3.5.6. Industry Consolidation
3.5.7. Pandemic / Unforeseen Disruptions Impact
3.6. Limitations
4. MACRO-ECONOMIC INDICATORS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates
4.2.2. Currency Coverage
4.2.2.1. Major Currencies Affecting the Market
4.2.2.2. Factors Affecting Currency Fluctuations
4.2.2.3. Impact of Currency Fluctuations on the Industry
4.2.3. Foreign Currency Exchange Rate
4.2.3.1. Impact of Foreign Exchange Rate Volatility on the Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
4.2.4. Recession
4.2.4.1. Assessment of Current Economic Conditions and Potential Impact on the Market
4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution
4.2.6. Interest Rates
4.2.6.1. Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk
4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Value and Weights
4.2.7.4. Modes of Transportation
4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario
4.2.8.3. Trade Policies
4.2.8.4. Strategies for Mitigating the Risks Associated with Trade Barriers
4.2.8.5. Impact of Trade Barriers on the Market
4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War
4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies
4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product (GDP)
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. Stock Market Performance
4.2.11.7. Cross-Border Dynamics
4.3. Conclusion
SECTION II: QUALITATIVE INSIGHTS5. EXECUTIVE SUMMARY
6. INTRODUCTION
6.1. Chapter Overview
6.2. Overview of Medical Devices
6.2.1. Historical Evolution of Medical Devices
6.2.2. Classification of Medical Devices
6.3. Overview of Contract Research Organizations
6.3.1. Evolution of CROs
6.4. Role of CROs in the Medical Device Industry
6.5. Type of Medical Device CROs
6.6. Type of Services Offered by CROs
6.7. Advantages of Outsourcing Operations to CROs
6.8. Risks and Challenges Associated with Outsourcing
6.9. Key Considerations for Selecting a Suitable CRO Partner
6.10. Concluding Remarks
7. REGULATORY AND REIMBURSEMENT LANDSCAPE FOR MEDICAL DEVICES
7.1. Chapter Overview
7.2. Regulatory and Reimbursement Guidelines for Medical Devices
7.3. Regulatory and Reimbursement Landscape in North America
7.3.1. The US Scenario
7.3.1.1. Regulatory Authority
7.3.1.2. Review / Approval Process
7.3.1.3. Reimbursement Landscape
7.3.1.3.1. Payer Mix
7.3.1.3.2. Reimbursement Process
7.3.2. The Canadian Scenario
7.3.2.1. Regulatory Authority
7.3.2.2. Review / Approval Process
7.3.2.3. Reimbursement Landscape
7.3.2.3.1. Payer Mix
7.3.2.3.2. Reimbursement Process
7.3.3. The Mexican Scenario
7.3.3.1. Regulatory Authority
7.3.3.2. Review / Approval Process
7.3.3.3. Reimbursement Landscape
7.3.3.3.1. Payer Mix
7.4. Regulatory and Reimbursement Landscape in Europe
7.4.1. Overall Scenario
7.4.1.1. Overall Regulatory Authorities
7.4.1.2. Review / Approval Process
7.4.2. The UK Scenario
7.4.2.1. Regulatory Authority
7.4.2.2. Review / Approval Process
7.4.2.3. Reimbursement Landscape
7.4.2.3.1. Payer Mix
7.4.2.3.2. Reimbursement Process
7.4.3. The French Scenario
7.4.3.1. Regulatory Authority
7.4.3.2. Review / Approval Process
7.4.3.3. Reimbursement Landscape
7.4.3.3.1. Payer Mix
7.4.3.3.2. Reimbursement Process
7.4.4. The German Scenario
7.4.4.1. Regulatory Authority
7.4.4.2. Review / Approval Process
7.4.4.3. Reimbursement Landscape
7.4.4.3.1. Payer Mix
7.4.4.3.2. Reimbursement Process
7.4.5. The Italian Scenario
7.4.5.1. Regulatory Authority
7.4.5.2. Review / Approval Process
7.4.5.3. Reimbursement Landscape
7.4.5.3.1. Payer Mix
7.4.5.3.2. Reimbursement Process
7.4.6. The Spanish Scenario
7.4.6.1. Regulatory Authority
7.4.6.2. Review / Approval Process
7.4.6.3. Reimbursement Landscape
7.4.6.3.1. Payer Mix
7.4.6.3.2. Reimbursement Process
7.5. Regulatory and Reimbursement Landscape in Asia-Pacific and Rest of the World
7.5.1. The Australian Scenario
7.5.1.1. Regulatory Authority
7.5.1.2. Review / Approval Process
7.5.1.3. Reimbursement Landscape
7.5.1.3.1. Payer Mix
7.5.1.3.2. Reimbursement Process
7.5.2. The Brazilian Scenario
7.5.2.1. Regulatory Authority
7.5.2.2. Review / Approval Process
7.5.2.3. Reimbursement Landscape
7.5.2.3.1. Payer Mix
7.5.2.3.2. Reimbursement Process
7.5.3. The Chinese Scenario
7.5.3.1. Regulatory Authority
7.5.3.2. Review / Approval Process
7.5.3.3. Reimbursement Landscape
7.5.3.3.1. Payer Mix
7.5.3.3.2. Reimbursement Process
7.5.4. The Indian Scenario
7.5.4.1. Regulatory Authority
7.5.4.2. Review / Approval Process
7.5.4.3. Reimbursement Landscape
7.5.4.3.1. Payer Mix
7.5.5. The Israeli Scenario
7.5.5.1. Regulatory Authority
7.5.5.2. Review / Approval Process
7.5.5.3. Reimbursement Landscape
7.5.5.3.1. Payer Mix
7.5.6. The Japanese Scenario
7.5.6.1. Regulatory Authority
7.5.6.2. Review / Approval Process
7.5.6.3. Reimbursement Landscape
7.5.6.3.1. Payer Mix
7.5.6.3.2. Reimbursement Process
7.5.7. The New Zealand Scenario
7.5.7.1. Regulatory Authority
7.5.7.2. Review / Approval Process
7.5.7.3. Reimbursement Landscape
7.5.7.3.1. Payer Mix
7.5.7.3.2. Reimbursement Process
7.5.8. The Singapore Scenario
7.5.8.1. Regulatory Authority
7.5.8.2. Review / Approval Process
7.5.8.3. Reimbursement Landscape
7.5.8.3.1. Payer Mix
7.5.8.3.2. Reimbursement Process
7.5.9. The South African Scenario
7.5.9.1. Regulatory Authority
7.5.9.2. Review / Approval Process
7.5.9.3. Reimbursement Landscape
7.5.9.3.1. Payer Mix
7.5.9.3.2. Reimbursement Process
7.5.10. The South Korean Scenario
7.5.10.1. Regulatory Authority
7.5.10.2. Review / Approval Process
7.5.10.3. Reimbursement Landscape
7.5.11. The Taiwan Scenario
7.5.11.1. Regulatory Authority
7.5.11.2. Review / Approval Process
7.5.11.3. Reimbursement Landscape
7.5.11.3.1. Payer Mix
7.5.11.3.2. Reimbursement Process
7.5.12. The Thailand Scenario
7.5.12.1. Regulatory Authority
7.5.12.2. Review / Approval Process
7.5.12.3. Reimbursement Landscape
7.6. Comparison of Regional Regulatory Control
7.7. Concluding Remarks
SECTION III: COMPETITIVE LANDSCAPE
8. MEDICAL DEVICE PRECLINICAL CROs: MARKET LANDSCAPE
8.1. Chapter Overview
8.2. Medical Device Preclinical CROs: Overall Market Landscape
8.2.1. Analysis by Year of Establishment
8.2.2. Analysis by Company Size
8.2.3. Analysis by Location of Headquarters
8.2.4. Analysis by Company Size and Location of Headquarters
8.2.5. Analysis by Type of Company
8.2.6. Analysis by Type of Preclinical Service Offered
9. MEDICAL DEVICE CLINICAL CROs: MARKET LANDSCAPE
9.1. Chapter Overview
9.2. Medical Device Clinical CROs: Overall Market Landscape
9.2.1. Analysis by Year of Establishment
9.2.2. Analysis by Company Size
9.2.3. Analysis by Location of Headquarters
9.2.4. Analysis by Type of Company
9.2.5. Analysis by Class of Medical Device
9.2.6. Analysis by Type of Clinical Trial Service Offered
9.2.7. Analysis by Type of Regulatory Service Offered
9.2.8. Analysis by Type of Medical Device Regulatory Compliance Authority
9.2.9. Analysis by Type of Additional Service Offered
10. BRAND POSITIONING ANALYSIS: PRECLINICAL MEDICAL DEVICE CROs
10.1. Chapter Overview
10.2. Assumptions and Key Parameters
10.3. Methodology
10.4. Brand Positioning Analysis : Preclinical CROs
10.4.1. Brand Positioning Analysis: Accuprec Research Labs
10.4.2. Brand Positioning Analysis: Alera Labs
10.4.3. Brand Positioning Analysis: Eurofins Medical Device Testing
10.4.4. Brand Positioning Analysis: Fortrea
10.4.5. Brand Positioning Analysis: iuvo BioScience
10.4.6. Brand Positioning Analysis: NAMSA
10.4.7. Brand Positioning Analysis: Sipra Labs
10.4.8. Brand Positioning Analysis: Tentamus
10.4.9. Brand Positioning Analysis: Veranex
10.4.10. Brand Positioning Analysis: WuXi AppTec
11. COMPETITIVE BENCHMARKING: CLINICAL CROs
11.1. Chapter Overview
11.2. Assumptions and Methodology
11.3. Competitive Benchmarking by Location of Headquarters and Company Size
11.3.1. Competitive Benchmarking: Small Players based in North America (Peer Group I)
11.3.2. Competitive Benchmarking: Mid-sized Players based in North America (Peer Group II)
11.3.3. Competitive Benchmarking: Large and Very Large Players based in North America (Peer Group III)
11.3.4. Competitive Benchmarking: Small Players based in Europe (Peer Group IV)
11.3.5. Competitive Benchmarking: Mid-sized Players based in Europe (Peer Group V)
11.3.6. Competitive Benchmarking: Large and Very Large Players based in Europe (Peer Group VI)
11.3.7. Competitive Benchmarking: Small Players based in Asia-Pacific (Peer Group VII)
11.3.8. Competitive Benchmarking: Mid-sized Players based in Asia-Pacific (Peer Group VIII)
11.3.9. Competitive Benchmarking: Large and Very Large Players based in Asia-Pacific (Peer Group IX)
11.3.10. Competitive Benchmarking: Small Players based in Middle East and North Africa, and Latin America (Peer Group X)
11.3.11. Competitive Benchmarking: Mid-sized Players based in Middle East and North Africa, and Latin America (Peer Group XI)
11.3.12. Competitive Benchmarking: Large and Very Large Players based in Middle East and North Africa, and Latin America (Peer Group XII)
11.4. Concluding Remarks
SECTION IV: COMPANY PROFILES
12. COMPANY PROFILES
12.1. Chapter Overview
12.2. Avania
12.2.1. Company Overview
12.2.2. Service Portfolio
12.2.3. Recent Developments and Future Outlook
12.3. Charles River Laboratories
12.4. CROMSOURCE
12.5. CSSi LifeSciences
12.6. Eurofins Medical Testing
12.7. IQVIA
12.8. Medpace
12.9. NAMSA
12.10. Qserve
12.11. WuXi AppTec
SECTION V: MARKET TRENDS
13. MERGERS AND ACQUISITIONS
13.1. Chapter Overview
13.2. Merger and Acquisition Models
13.3. Medical Device CROs: Mergers and Acquisitions
13.3.1. Analysis by Year of Merger / Acquisition
13.3.2. Analysis by Type of Agreement
13.3.3. Regional Analysis
13.3.3.1. Analysis by Continent
13.3.3.2. Intercontinental and Intracontinental Deals
13.3.3.3. Analysis by Country
13.3.4. Ownership Change Matrix
13.3.5. Analysis by Type of Company
13.3.6. Analysis by Key Value Drivers
13.3.6.1. Analysis by Year of Acquisition and Key Value Drivers
14. CLINICAL TRIAL ANALYSIS
14.1. Chapter Overview
14.2. Scope and Methodology
14.3. Clinical Trial Analysis: Medical Devices
14.3.1. Analysis by Trial Registration Year
14.3.2. Analysis of Number of Patients Enrolled by Trial Registration Year
14.3.3. Analysis by Trial Phase
14.3.4. Analysis of Number of Patients Enrolled by Trial Phase
14.3.5. Analysis by Trial Registration Year and Trial Phase
14.3.6. Analysis by Trial Status
14.3.7. Analysis by Patient Gender
14.3.8. Analysis by Target Indication
14.3.9. Analysis by Study Design
14.3.9.1. Analysis by Type of Trial Masking
14.3.9.2. Analysis by Type of Intervention Model
14.3.9.3. Analysis by Trial Purpose
14.3.9.4. Analysis by Design Allocation
14.3.10. Most Active Sponsor / Collaborator: Analysis by Number of Registered Trials
14.3.10.1. Analysis by Leading Industry Players
14.3.10.2. Analysis by Leading Non-Industry Players
14.3.11. Analysis by Geography
14.3.11.1. Analysis of Clinical Trials by Trial Status and Geography
14.3.11.2. Analysis of Patients Enrolled by Trial Status and Geography
15. FUTURE TRENDS AND OPPORTUNITIES
15.1. Chapter Overview
15.2. Anticipated Growth in Number of Connected Devices
15.3. Adoption of Data Analytics and Real-Time Monitoring Solutions
15.4. Need for Cloud-based Computing and Storage Solutions
15.5. Growing Demand for Real World Evidence to Obtain Regulatory Approval
15.6. Concluding Remarks
SECTION VI: MARKET FORECAST AND OPPORTUNITY ANALYSIS
16. SWOT ANALYSIS
16.1. Chapter Overview
16.2. Strengths
16.3. Weaknesses
16.4. Opportunities
16.5. Threats
16.6. Concluding Remarks
17. GLOBAL MEDICAL DEVICE CRO MARKET
17.1. Chapter Overview
17.2. Assumptions and Methodology
17.3. Roots Analysis Perspective on Market Growth
17.4. Global Medical Device CRO Market: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
17.4.1. Scenario Analysis
17.4.1.1. Conservative Scenario
17.4.1.2. Optimistic Scenario
17.5. Key Market Segmentations
18. MEDICAL DEVICE CRO MARKET, BY CLASS OF MEDICAL DEVICE
18.1. Chapter Overview
18.2. Assumptions and Methodology
18.3. Medical Device CRO Market: Distribution by Class of Medical Device
18.3.1. Medical Device CRO Market for Class I Medical Devices: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
18.3.2. Medical Device CRO Market for Class II Medical Devices: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
18.3.3. Medical Device CRO Market for Class III Medical Devices: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
18.4. Market Movement Analysis: Class of Medical Device
18.5. Penetration-Growth (P-G) Matrix: Class of Medical Device
18.6. Data Triangulation and Validation
19. MEDICAL DEVICE CRO MARKET, BY TYPE OF MEDICAL DEVICE
19.1. Chapter Overview
19.2. Assumptions and Methodology
19.3. Medical Device CRO Market: Distribution by Type of Medical Device
19.3.1. Medical Device CRO Market for MedTech Devices: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
19.3.2. Medical Device CRO Market for Diagnostic Devices: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
19.3.3. Medical Device CRO Market for Handheld Diagnostic Devices: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
19.3.4. Medical Device CRO Market for Other Devices: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
19.4. Penetration-Growth (P-G) Matrix: Type of Medical Device
19.5. Data Triangulation and Validation
20. MEDICAL DEVICE CRO MARKET, BY SCALE OF OPERATION
20.1. Chapter Overview
20.2. Assumptions and Methodology
20.3. Medical Device CRO Market: Distribution by Scale of Operation
20.3.1. Medical Device CRO Market for Preclinical Services: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
20.3.2. Medical Device CRO Market for Clinical Services: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
20.4. Penetration-Growth (P-G) Matrix: Scale of Operation
20.5. Data Triangulation and Validation
21. MEDICAL DEVICE CRO MARKET, BY TYPE OF PRECLINICAL SERVICE OFFERED
21.1. Chapter Overview
21.2. Assumptions and Methodology
21.3. Medical Device CRO Market: Distribution by Type of Preclinical Service Offered
21.3.1. Medical Device CRO Market for Sterility and Microbiology Testing Services: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
21.3.2. Medical Device CRO Market for Biocompatibility Testing Services: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
21.3.3. Medical Device CRO Market for Material Characterization and Analytical Services: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
21.3.4. Medical Device CRO Market for Other Services: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
21.4. Penetration-Growth (P-G) Matrix: Type of Preclinical Service Offered
21.5. Data Triangulation and Validation
22. MEDICAL DEVICE CRO MARKET, BY TYPE OF CLINICAL SERVICE OFFERED
22.1. Chapter Overview
22.2. Assumptions and Methodology
22.3. Medical Device CRO Market: Distribution by Type of Clinical Service Offered
22.3.1. Medical Device CRO Market for Clinical Trial Management Services: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
22.3.2. Medical Device CRO Market for Data Management Services: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
22.3.3. Medical Device CRO Market for Regulatory Support Services: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
22.3.4. Medical Device CRO Market for Consultancy Services: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
22.3.5. Medical Device CRO Market for Other Services: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
22.4. Penetration-Growth (P-G) Matrix: Type of Clinical Service Offered
22.5. Data Triangulation and Validation
23. MEDICAL DEVICE CRO MARKET, BY COMPANY SIZE
23.1. Chapter Overview
23.2. Assumptions and Methodology
23.3. Medical Device CRO Market: Distribution by Company Size
23.3.1. Medical Device CRO Market for Small Companies: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
23.3.2. Medical Device CRO Market for Mid-sized Companies: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
23.3.3. Medical Device CRO Market for Large and Very Large Companies: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
23.4. Penetration-Growth (P-G) Matrix: Company Size
23.5. Data Triangulation and Validation
24. MEDICAL DEVICE CRO MARKET, BY TYPE OF ORIGINAL EQUIPMENT MANUFACTURER
24.1. Chapter Overview
24.2. Assumptions and Methodology
24.3. Medical Device CRO Market: Distribution by Type of Original Equipment Manufacturer
24.3.1. Medical Device CRO Market for Small and Mid-sized CROs: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
24.3.2. Medical Device CRO Market for Large CROs: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
24.3.3. Medical Device CRO Market for Very Large CROs: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
24.4. Penetration-Growth (P-G) Matrix: Type of Original Equipment Manufacturer
24.5. Data Triangulation and Validation
25. MEDICAL DEVICE CRO MARKET, BY TARGET INDICATION
25.1. Chapter Overview
25.2. Assumptions and Methodology
25.3. Medical Device CRO Market: Distribution by Target Indication
25.3.1. Medical Device CRO Market for Cardiovascular Disorders: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
25.3.2. Medical Device CRO Market for Oncological Disorders: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
25.3.3. Medical Device CRO Market for Neurological Disorders: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
25.3.4. Medical Device CRO Market for Orthopedic Disorders: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
25.3.5. Medical Device CRO Market for Respiratory Disorders: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
25.3.6. Medical Device CRO Market for Pain Disorders: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
25.3.7. Medical Device CRO Market for Ophthalmological Disorders: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
25.3.8. Medical Device CRO Market for Psychological Disorders: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
25.3.9. Medical Device CRO Market for Metabolic Disorders: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
25.3.10. Medical Device CRO Market for Other Disorders: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
25.4. Penetration-Growth (P-G) Matrix: Target Indication
25.5. Data Triangulation and Validation
26. MEDICAL DEVICE CRO MARKET, BY GEOGRAPHICAL REGIONS
26.1. Chapter Overview
26.2. Assumptions and Methodology
26.3. Medical Device CRO Market: Distribution by Geographical Regions
26.3.1. Medical Device CRO Market in North America: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.1.1. Medical Device CRO Market in the US: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.1.2. Medical Device CRO Market in Canada: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.2. Medical Device CRO Market in Europe: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.2.1. Medical Device CRO Market in Germany: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.2.2. Medical Device CRO Market in France: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.2.3. Medical Device CRO Market in Italy: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.2.4. Medical Device CRO Market in Spain: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.2.5. Medical Device CRO Market in the UK: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.2.6. Medical Device CRO Market in Switzerland: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.2.7. Medical Device CRO Market in Poland: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.2.8. Medical Device CRO Market in Belgium: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.2.9. Medical Device CRO Market in Austria: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.2.10. Medical Device CRO Market in the Netherlands: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.2.11. Medical Device CRO Market in Rest of Europe: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.3. Medical Device CRO Market in Asia-Pacific: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.3.1. Medical Device CRO Market in Japan: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.3.2. Medical Device CRO Market in China: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.3.3. Medical Device CRO Market in India: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.3.4. Medical Device CRO Market in South Korea: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.3.5. Medical Device CRO Market in Australia: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.3.6. Medical Device CRO Market in Indonesia: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.3.7. Medical Device CRO Market in Thailand: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.3.8. Medical Device CRO Market in Singapore: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.3.9. Medical Device CRO Market in Rest of Asia-Pacific: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.4. Medical Device CRO Market in Middle East and North Africa: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.4.1. Medical Device CRO Market in Saudi Arabia: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.4.2. Medical Device CRO Market in Egypt: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.4.3. Medical Device CRO Market in Israel: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.4.4. Medical Device CRO Market in Rest of Middle East and North Africa: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.5. Medical Device CRO Market in Latin America: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.5.1. Medical Device CRO Market in Brazil: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.5.2. Medical Device CRO Market in Mexico: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.5.3. Medical Device CRO Market in Argentina: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.3.5.4. Medical Device CRO Market in Rest of Latin America: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
26.4. Penetration-Growth (P-G) Matrix: Geographical Regions
26.5. Data Triangulation and Validation
27. MEDICAL DEVICE CRO MARKET, BY LEADING PLAYERSSECTION VII: CASE STUDY
28. MEDICAL DEVICE DEVELOPER AND CRO RELATIONSHIPS: KEY VALUE DRIVERS AND PERFORMANCE INDICATORS
28.1. Chapter Overview
28.2. Overview and Significance of Key Performance Indicators (KPIs)
28.3. Key Considerations while Selecting KPIs
28.4. Types of KPIs
28.4.1. Financial Indicators
28.4.1.1. Most Important KPIs
28.4.1.1.1. Financial Stability
28.4.1.1.2. Cost of Services Offered
28.4.1.1.3. Comparative Analysis of Financial Indicators
28.4.1.2. Industry Perspective
28.4.1.2.1. Sponsors’ (Big Pharma) Perspective
28.4.1.2.2. Contract Service Providers’ Perspective
28.4.2. Process and Capability Indicators
28.4.2.1. Most Important KPIs
28.4.2.1.1. Proximity to Sponsor
28.4.2.1.2. Capability to Innovate / Mitigate Risk
28.4.2.1.3. Service Portfolio Strength
28.4.2.1.4. Comparative Analysis of Process and Capability Indicators
28.4.2.2. Industry Perspective
28.4.2.2.1. Sponsors’ (Big Pharma) Perspective
28.4.2.2.2. Contract Service Providers’ Perspective
28.4.3. Market Reputation Indicators
28.4.3.1. Most Important KPIs
28.4.3.1.1. Flexibility / Adaptability
28.4.3.1.2. Time Management
28.4.3.1.3. Quality / Reliability
28.4.3.1.4. Regulatory Compliance / Track Record
28.4.3.1.5. Comparative Analysis of Market Reputation Indicators
28.4.3.2. Industry Perspective
28.4.3.2.1. Sponsors’ (Big Pharma) Perspective
28.4.3.2.2. Contract Service Providers’ Perspective
28.5. Comparison of Key Performance Indicators
28.6. Concluding Remarks
29. TOTAL COST OF OWNERSHIP FOR MEDICAL DEVICES CROs
29.1. Chapter Overview
29.2. Key Parameters
29.3. Assumptions and Methodology
29.4. Sample Dataset for the estimation of Total Cost of Ownership
29.4.1. Total Cost of Ownership for Large Medical Device Contract Research Organizations, Y0-Y20
29.4.2. Total Cost of Ownership for Large Medical Device Contract Research Organizations: Analysis by CAPEX, Y0
29.4.3. Total Cost of Ownership for Large Medical Device Contract Research Organizations: Analysis by OPEX, Y1-Y20
30. CASE STUDY: LIST OF ADDITIONAL MEDICAL DEVICE CROs
30.1. Chapter Overview
30.2. Medical Device CROs: Overall Market Landscape
30.2.1. Analysis by Year of Establishment
30.2.2. Analysis by Company Size
30.2.3. Analysis by Location of Headquarters
30.2.4. Analysis by Type of Company
SECTION VIII: OTHER EXCLUSIVE INSIGHTS31. CONCLUSION
32. EXECUTIVE INSIGHTS
32.1. Chapter Overview
32.2. Mid-sized Company, Hungary
32.2.1. Company Overview
32.2.2. Interview Transcript
32.3. Large Company, US
32.3.1. Company Overview
32.3.2. Interview Transcript
32.4. Large Company, US
32.4.1. Company Overview
32.4.2. Interview Transcript
32.5. Large Company, US
32.5.1. Company Overview
32.5.2. Interview Transcript
32.6. Very Large Company, China
32.6.1. Company Overview
32.6.2. Interview Transcript
32.7. Small Company, Sweden
32.7.1. Company Overview
32.7.2. Interview Transcript
32.8. Mid-sized Company, Canada
32.8.1. Company Overview
32.8.2. Interview Transcript
32.9. Small Company, India
32.9.1. Company Overview
32.9.2. Interview Transcript
32.10. Small Company, India
32.10.1. Company Overview
32.10.2. Interview Transcript
32.11. Small Company, Germany
32.11.1. Company Overview
32.11.2. Interview Transcript
32.12. Mid-sized Company, Pakistan
32.12.1. Company Overview
32.12.2. Interview Transcript
32.13. Mid-sized Company, Germany
32.13.1. Company Overview
32.13.2. Interview Transcript
32.14. Small Company, Germany
32.14.1. Company Overview
32.14.2. Interview Transcript
SECTION IX: APPENDICES33. APPENDIX I: TABULATED DATA34. APPENDIX II: LIST OF ADDITIONAL MEDICAL DEVICE CLINICAL CROs35. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
LIST OF FIGURES
Figure 2.1 Executive Summary: Overall Market Landscape
Figure 2.2 Executive Summary: Clinical Trial Analysis
Figure 2.3 Executive Summary: Mergers and Acquisitions
Figure 2.4 Executive Summary: Total Cost of Ownership
Figure 2.5 Executive Summary: Market Sizing and Opportunity Analysis (1/2)
Figure 2.6 Executive Summary: Market Sizing and Opportunity Analysis (2/2)
Figure 3.1 Historical Timeline of Medical Device Inventions
Figure 3.2 Medical Device: Development Process and Timeline
Figure 3.3 Types of CROs Engaged in the Medical Device Market
Figure 3.4 Services Offered by CROs
Figure 3.5 Risks / Challenges Associated with Outsourcing Operations to CROs
Figure 4.1 Medical Device Clinical CROs: Distribution by Year of Establishment
Figure 4.2 Medical Device Clinical CROs: Distribution by Company Size
Figure 4.3 Medical Device Clinical CROs: Distribution by Location of Headquarters
Figure 4.4 Medical Device Clinical CROs: Distribution by Company Size and Location of Headquarters
Figure 4.5 Medical Device Clinical CROs: Distribution by Area of Specialization
Figure 4.6 Medical Device Clinical CROs: Distribution by Device Class
Figure 4.7 Medical Device Clinical CROs: Distribution by Type of Clinical Operation Service Offered
Figure 4.8 Medical Device Clinical CROs: Distribution by Year of Establishment, Type of Clinical Service Offered and Geography
Figure 4.9 Medical Device Clinical CROs: Distribution by Type of Regulatory Affairs-related Service Offered
Figure 4.10 Medical Device Clinical CROs: Distribution by Type of Additional Service Offered
Figure 4.11 Medical Device Clinical CROs: Distribution by Type of Medical Device Regulatory Compliance Authority
Figure 4.12 Medical Device Preclinical CROs: Distribution by Year of Establishment
Figure 4.13 Medical Device Preclinical CROs: Distribution by Company Size
Figure 4.14 Medical Device Preclinical CROs: Distribution by Location of Headquarters
Figure 4.15 Medical Device Preclinical CROs: Distribution by Company Size and Location of Headquarters
Figure 4.16 Medical Device Preclinical CROs: Distribution by Type of Preclinical Service Offered
Figure 4.17 Medical Device Preclinical CROs: Distribution by Year of Establishment, Type of Preclinical Service Offered and Geography
Figure 4.18 Medical Device Standalone CROs: Distribution by Year of Establishment
Figure 4.19 Medical Device Standalone CROs: Distribution by Company Size
Figure 4.20 Medical Device Standalone CROs: Distribution by Location of Headquarters
Figure 4.21 Medical Device Standalone CROs: Distribution by Company Size and Location of Headquarters
Figure 5.1 Key Regulatory Authorities for Medical Devices
Figure 5.2 Medical Devices Review / Approval Process in the US
Figure 5.3 Healthcare Insurance Coverage in the US: Distribution by Type of Coverage
Figure 5.4 Medical Devices National Coverage Determination Process in the US
Figure 5.5 Medical Devices Review / Approval Process in Canada
Figure 5.6 Healthcare Insurance Coverage in Canada: Distribution by Type of Coverage
Figure 5.7 Medical Devices Review / Approval Process in Mexico
Figure 5.8 Regulatory Bodies in EU5 Countries
Figure 5.9 Steps involved in CE Marking Process
Figure 5.10 Medical Devices Review / Approval Process in Europe
Figure 5.11 Medical Devices Review / Approval Process in the UK
Figure 5.12 Healthcare Insurance Coverage in the UK: Distribution by Type of Coverage
Figure 5.13 Reimbursement Process for Medical Devices in the UK
Figure 5.14 Healthcare Insurance Coverage in France: Distribution by Type of Coverage
Figure 5.15 Reimbursement Process for Medical Devices through List of Products and Services Qualifying for Reimbursement
Figure 5.16 Healthcare Insurance Coverage in Germany: Distribution by Type of Coverage
Figure 5.17 Reimbursement Process for In-Patient Setting in Germany
Figure 5.18 Reimbursement Process for Out-Patient Care in Germany
Figure 5.19 Healthcare Insurance Coverage in Italy: Distribution by Type of Coverage
Figure 5.20 Reimbursement Process for Medical Devices in Italy
Figure 5.21 Healthcare Insurance Coverage in Spain: Distribution by Type of Coverage
Figure 5.22 Reimbursement Process for Medical Devices in Spain
Figure 5.23 Medical Devices Review / Approval Process in Australia
Figure 5.24 Healthcare Insurance Coverage in Australia: Distribution by Type of Coverage
Figure 5.25 Medical Devices Review / Approval Process in Brazil
Figure 5.26 Reimbursement Process for Medical Devices in Brazil
Figure 5.27 Medical Devices Review / Approval Process in China
Figure 5.28 Healthcare Insurance Coverage in China: Distribution by Type of Coverage
Figure 5.29 Reimbursement Approval Process for Medical Devices in Shanghai
Figure 5.30 Medical Devices Review / Approval Process in India
Figure 5.31 Healthcare Insurance Coverage in Israel: Distribution by Type of Coverage
Figure 5.32 Medical Devices Review / Approval Process in Japan
Figure 5.33 Snapshot of the Regulatory and Reimbursement Process in Japan
Figure 5.34 Healthcare Insurance Coverage in Japan: Distribution by Type of Coverage
Figure 5.35 Reimbursement Process for New Medical Devices in Japan
Figure 5.36 Medical Devices Review / Approval Process in New Zealand
Figure 5.37 Healthcare Insurance Coverage in New Zealand: Distribution by Type of Coverage
Figure 5.38 Medical Devices Review / Approval Process in Singapore
Figure 5.39 Medical Devices Review / Approval Process in South Korea
Figure 5.40 Healthcare Insurance Coverage in South Korea: Distribution by Type of Coverage
Figure 5.41 Medical Devices Review / Approval Process in South Africa
Figure 5.42 Medical Devices Review / Approval Process in Taiwan
Figure 5.43 Healthcare Insurance Coverage in Taiwan: Distribution by Type of Coverage
Figure 5.44 Medical Devices Review / Approval Process in Thailand
Figure 5.45 Heat Map Analysis: Comparison of Regional Regulatory Control for Medical Devices
Figure 5.46 Regulatory Control for Medical Devices: Regional Distribution by Device Risk Category
Figure 6.1 Avania: Service Portfolio
Figure 6.2 Charles River Laboratories: Service Portfolio
Figure 6.3 CROMSOURCE: Service Portfolio
Figure 6.4 CSSi LifeSciences: Service Portfolio
Figure 6.5 Eurofins Medical Device Testing: Preclinical Service Portfolio
Figure 6.6Eurofins Medical Device Testing: Clinical Service Portfolio
Figure 6.7 IQVIA: Service Portfolio
Figure 6.8 Medpace: Service Portfolio
Figure 6.9 NAMSA: Service Portfolio
Figure 6.10 Qserve Group: Service Portfolio
Figure 6.11 WuXi AppTec: Preclinical Service Portfolio
Figure 6.12 WuXi AppTec: Clinical Service Portfolio
Figure 7.1Key Attributes for Selection of Key Performance Indicators (KPIs)
Figure 7.2 Types of KPIs
Figure 7.3 Financial Indicators: Comparative Analysis of KPIs considered by Big Pharma Companies
Figure 7.4 Financial Indicators: Sponsors’ (Big Pharma) Perspective
Figure 7.5 Financial Indicators: Contract Service Providers’ Perspective
Figure 7.6 Process / Capability Indicators: Comparative Analysis of KPIs considered by Big Pharma Companies
Figure 7.7 Process / Capability Indicators: Sponsors’ (Big Pharma) Perspective
Figure 7.8 Process / Capability Indicators: Contract Service Providers’ Perspective
Figure 7.9 Market Reputation Indicators: Comparative Analysis of KPIs considered by Big Pharma Companies
Figure 7.10 Market Reputation Indicators: Sponsors’ (Big Pharma) Perspective
Figure 7.11 Market Reputation Indicators: Contract Service Providers’ Perspective
Figure 7.12 Comparison of Key Factors to be considered while selecting KPIs for Medical Devices
Figure 8.1 Competitive Benchmarking: Distribution by Region and Company Size
Figure 8.2 Competitive Benchmarking: Small Players based in North America (Peer Group I)
Figure 8.3 Competitive Benchmarking: Mid-sized Players based in North America (Peer Group II)
Figure 8.4 Competitive Benchmarking: Large Players based in North America (Peer Group III)
Figure 8.5 Competitive Benchmarking: Small Players based in Europe (Peer Group IV)
Figure 8.6 Competitive Benchmarking: Mid-sized Players based in Europe (Peer Group V)
Figure 8.7 Competitive Benchmarking: Large Players based in Europe (Peer Group VI)
Figure 8.8 Competitive Benchmarking: Small Players based in Asia-Pacific (Peer Group VII)
Figure 8.9 Competitive Benchmarking: Mid-sized Players based in Asia-Pacific (Peer Group VIII)
Figure 8.10 Competitive Benchmarking: Large Players based in Asia-Pacific (Peer Group IX)
Figure 8.11 Competitive Benchmarking: Small Players based in Rest of the World (Peer Group X)
Figure 8.12 Competitive Benchmarking: Mid-sized Players based in Rest of the World (Peer Group XI)
Figure 8.13Competitive Benchmarking Summary
Figure 9.1 Brand Positioning of Key Industry Players: Unfair Advantage
Figure 9.2 Brand Positioning of Key Industry Players: Reasons to Believe
Figure 9.3 Brand Positioning Matrix: Labcorp
Figure 9.4 Brand Positioning Matrix: IQVIA
Figure 9.5 Brand Positioning Matrix: Syneos Health
Figure 9.6 Brand Positioning Matrix: PPD
Figure 9.7 Brand Positioning Matrix: ICON
Figure 9.8 Brand Positioning Matrix: Charles River Laboratories
Figure 9.9 Brand Positioning Matrix: WuXi AppTec
Figure 9.10 Brand Positioning Matrix: Medpace
Figure 10.1 Clinical Trial Analysis: Distribution by Trial Registration Year, Since 2015
Figure 10.2 Clinical Trial Analysis: Distribution by Trial Status
Figure 10.3 Clinical Trial Analysis: Distribution by Phase of Development
Figure 10.4 Clinical Trial Analysis: Distribution by Study Design
Figure 10.5 Clinical Trial Analysis: Distribution by Therapeutic Area
Figure 10.6 Clinical Trial Analysis: Distribution by Geography
Figure 10.7 Clinical Trial Analysis: Distribution by Trial Registration Year and Geography
Figure 10.8 Clinical Trial Analysis: Distribution by Trial Status and Geography
Figure 10.9 Clinical Trial Analysis: Distribution by Type of Sponsor
Figure 10.10 Most Active Players: Distribution by Number of Clinical Trials
Figure 10.11 Clinical Trial Analysis: Distribution of Enrolled Patient Population by Trial Registration Year
Figure 10.12 Clinical Trial Analysis: Distribution of Enrolled Patient Population by Phase of Development
Figure 10.13 Clinical Trial Analysis: Distribution of Enrolled Patient Population by Geography
Figure 10.14 Clinical Trial Analysis: Distribution of Enrolled Patient Population by Trial Status and Geography
Figure 11.1 Mergers and Acquisitions: Cumulative Year-Wise Trend (since 2015)
Figure 11.2 Mergers and Acquisitions: Distribution by Type of Agreement
Figure 11.3 Mergers and Acquisitions: Distribution by Year and Type of Agreement
Figure 11.4 Mergers and Acquisitions: Continent-wise Distribution
Figure 11.5 Mergers and Acquisitions: Intercontinental and Intracontinental Acquisitions
Figure 11.6 Mergers and Acquisitions: Country-wise Distribution
Figure 11.7 Mergers and Acquisitions: Ownership Change Matrix
Figure 11.8 Mergers and Acquisitions: Distribution by Type of Company
Figure 11.9 Mergers and Acquisitions: Distribution by Key Value Drivers
Figure 11.10 Mergers and Acquisitions: Distribution by Year of Acquisition and Key Value Drivers
Figure 12.1Total Cost of Ownership: Capital Expenditures (CAPEX)
Figure 12.2Total Cost of Ownership: Operational Expenditures (OPEX)
Figure 12.3Total Cost of Ownership for Large Medical Device Contract Research Organizations, Y0-Y20 (USD Million)
Figure 12.4Total Cost of Ownership for Large Medical Device Contract Research Organizations, Y0: Distribution of CAPEX (USD Million)
Figure 12.5Total Cost of Ownership for Large Medical Device Contract Research Organizations, Y1-Y20: Distribution by OPEX (USD Million)
Figure 13.1 Survey Insights: Distribution of Respondents by Designation and Seniority Level
Figure 13.2 Survey Insights: Distribution of Respondents by Type of Service Offered
Figure 13.3 Survey Insights: Distribution of Respondents by Therapeutic Area
Figure 13.4 Survey Insights: Distribution of Respondents by Average Number of Annual Projects
Figure 13.5 Survey Insights: Distribution of Respondents by Market Opportunity
Figure 14.1 Overall Medical Device CROs Market, till 2035 (USD Billion)
Figure 14.2 Medical Device CROs Market, 2022, 2028 and 2035: Distribution by Therapeutic Area (USD Billion)
Figure 14.3 Medical Device CROs Market, till 2035: Distribution by Scale of Operation (USD Billion)
Figure 14.4 Medical Device CROs Market, till 2035: Distribution by Device Class (USD Billion)
Figure 14.5 Medical Device CROs Market, till 2035: Distribution by Type of Clinical Service Offered (USD Billion)
Figure 14.6 Medical Device CROs Market, till 2035: Distribution by Type of Preclinical Service Offered (USD Billion)
Figure 14.7 Medical Device CROs Market, 2022, 2028 and 2035: Distribution by Geography (USD Billion)
Figure 14.8 Medical Device CROs Market in North America, till 2035 (USD Billion)
Figure 14.9 Medical Device CROs Market for CNS Disorders in North America, till 2035 (USD Billion)
Figure 14.10 Medical Device CROs Market for Cardiovascular Disorders in North America, till 2035 (USD Billion)
Figure 14.11 Medical Device CROs Market for Oncological Disorders in North America, till 2035 (USD Billion)
Figure 14.12 Medical Device CROs Market for Bone Disorders in North America, till 2035 (USD Billion)
Figure 14.13 Medical Device CROs Market for Respiratory Disorders in North America, till 2035 (USD Billion)
Figure 14.14 Medical Device CROs Market for Pain Disorders in North America, till 2035 (USD Billion)
Figure 14.15 Medical Device CROs Market for Ophthalmic Disorders in North America, till 2035 (USD Billion)
Figure 14.16 Medical Device CROs Market for Psychological Disorders in North America, till 2035 (USD Billion)
Figure 14.17 Medical Device CROs Market for Metabolic Disorders in North America, till 2035 (USD Billion)
Figure 14.18 Medical Device CROs Market for Other Disorders in North America, till 2035 (USD Billion)
Figure 14.19 Medical Device CROs Market for Class I Devices in North America, till 2035 (USD Billion)
Figure 14.20 Medical Device CROs Market for Class II Devices in North America, till 2035 (USD Billion)
Figure 14.21 Medical Device CROs Market for Class III Devices in North America, till 2035 (USD Billion)
Figure 14.22 Medical Device CROs Market for Clinical Trial Management Services in North America, till 2035 (USD Billion)
Figure 14.23 Medical Device CROs Market for Consulting Services in North America, till 2035 (USD Billion)
Figure 14.24 Medical Device CROs Market for Data Management Services in North America, till 2035 (USD Billion)
Figure 14.25 Medical Device CROs Market for Regulatory Affairs Management Services in North America, till 2035 (USD Billion)
Figure 14.26 Medical Device CROs Market for Other Clinical Services in North America, till 2035 (USD Billion)
Figure 14.27 Medical Device CROs Market for Material Characterization and Analytical Services in North America, till 2035 (USD Billion)
Figure 14.28 Medical Device CROs Market for Biocompatibility Testing Services in North America, till 2035 (USD Billion)
Figure 14.29 Medical Device CROs Market for Sterility and Microbiology Testing Services in North America, till 2035 (USD Billion)
Figure 14.30 Medical Device CROs Market for Other Preclinical Services in North America, till 2035 (USD Billion)
Figure 14.31 Medical Device CROs Market in Europe, till 2035 (USD Billion)
Figure 14.32 Medical Device CROs Market for CNS Disorders in Europe, till 2035 (USD Billion)
Figure 14.33 Medical Device CROs Market for Cardiovascular Disorders in Europe, till 2035 (USD Billion)
Figure 14.34 Medical Device CROs Market for Oncological Disorders in Europe, till 2035 (USD Billion)
Figure 14.35 Medical Device CROs Market for Bone Disorders in Europe, till 2035 (USD Billion)
Figure 14.36 Medical Device CROs Market for Respiratory Disorders in Europe, till 2035 (USD Billion)
Figure 14.37 Medical Device CROs Market for Pain Disorders in Europe, till 2035 (USD Billion)
Figure 14.38 Medical Device CROs Market for Ophthalmic Disorders in Europe, till 2035 (USD Billion)
Figure 14.39 Medical Device CROs Market for Psychological Disorders in Europe, till 2035 (USD Billion)
Figure 14.40 Medical Device CROs Market for Metabolic Disorders in Europe, till 2035 (USD Billion)
Figure 14.41 Medical Device CROs Market for Other Disorders in Europe, till 2035 (USD Billion)
Figure 14.42 Medical Device CROs Market for Class I Devices in Europe, till 2035 (USD Billion)
Figure 14.43 Medical Device CROs Market for Class II Devices in Europe, till 2035 (USD Billion)
Figure 14.44 Medical Device CROs Market for Class III Devices in Europe, till 2035 (USD Billion)
Figure 14.45 Medical Device CROs Market for Clinical Trial Management Services in Europe, till 2035 (USD Billion)
Figure 14.46 Medical Device CROs Market for Consulting Services in Europe, till 2035 (USD Billion)
Figure 14.47 Medical Device CROs Market for Data Management Services in Europe, till 2035 (USD Billion)
Figure 14.48 Medical Device CROs Market for Regulatory Affairs Management Services in Europe, till 2035 (USD Billion)
Figure 14.49 Medical Device CROs Market for Other Clinical Services in Europe, till 2035 (USD Billion)
Figure 14.50 Medical Device CROs Market for Material Characterization and Analytical Services in Europe, till 2035 (USD Billion)
Figure 14.51 Medical Device CROs Market for Biocompatibility Testing Services in Europe, till 2035 (USD Billion)
Figure 14.52 Medical Device CROs Market for Sterility and Microbiology Testing Services in Europe, till 2035 (USD Billion)
Figure 14.53 Medical Device CROs Market for Other Preclinical Services in Europe, till 2035 (USD Billion)
Figure 14.54 Medical Device CROs Market in Asia-Pacific, till 2035 (USD Billion)
Figure 14.55 Medical Device CROs Market for CNS Disorders in Asia-Pacific, till 2035 (USD Billion)
Figure 14.56 Medical Device CROs Market for Cardiovascular Disorders in Asia-Pacific, till 2035 (USD Billion)
Figure 14.57 Medical Device CROs Market for Oncological Disorders in Asia-Pacific, till 2035 (USD Billion)
Figure 14.58 Medical Device CROs Market for Bone Disorders in Asia-Pacific, till 2035 (USD Billion)
Figure 14.59 Medical Device CROs Market for Respiratory Disorders in Asia-Pacific, till 2035 (USD Billion)
Figure 14.60 Medical Device CROs Market for Pain Disorders in Asia-Pacific, till 2035 (USD Billion)
Figure 14.61 Medical Device CROs Market for Ophthalmic Disorders in Asia-Pacific, till 2035 (USD Billion)
Figure 14.62 Medical Device CROs Market for Psychological Disorders in Asia-Pacific, till 2035 (USD Billion)
Figure 14.63 Medical Device CROs Market for Metabolic Disorders in Asia-Pacific, till 2035 (USD Billion)
Figure 14.64 Medical Device CROs Market for Other Disorders in Asia-Pacific, till 2035 (USD Billion)
Figure 14.65 Medical Device CROs Market for Class I Devices in Asia-Pacific, till 2035 (USD Billion)
Figure 14.66 Medical Device CROs Market for Class II Devices in Asia-Pacific, till 2035 (USD Billion)
Figure 14.67 Medical Device CROs Market for Class III Devices in Asia-Pacific, till 2035 (USD Billion)
Figure 14.68 Medical Device CROs Market for Clinical Trial Management Services in Asia-Pacific, till 2035 (USD Billion)
Figure 14.69 Medical Device CROs Market for Consulting Services in Asia-Pacific, till 2035 (USD Billion)
Figure 14.70 Medical Device CROs Market for Data Management Services in Asia-Pacific, till 2035 (USD Billion)
Figure 14.71 Medical Device CROs Market for Regulatory Affairs Management Services in Asia-Pacific, till 2035 (USD Billion)
Figure 14.72 Medical Device CROs Market for Other Clinical Services in Asia-Pacific, till 2035 (USD Billion)
Figure 14.73 Medical Device CROs Market for Material Characterization and Analytical Services in Asia-Pacific, till 2035 (USD Billion)
Figure 14.74 Medical Device CROs Market for Biocompatibility Testing Services in Asia-Pacific, till 2035 (USD Billion)
Figure 14.75 Medical Device CROs Market for Sterility and Microbiology Testing Services in Asia-Pacific, till 2035 (USD Billion)
Figure 14.76 Medical Device CROs Market for Other Preclinical Services in Asia-Pacific, till 2035 (USD Billion)
Figure 14.77 Medical Device CROs Market in Rest of the World, till 2035 (USD Billion)
Figure 14.78 Medical Device CRO Market for CNS Disorders in Rest of the World, till 2035 (USD Billion)
Figure 14.79 Medical Device CROs Market for Cardiovascular Disorders in Rest of the World, till 2035 (USD Billion)
Figure 14.80 Medical Device CROs Market for Oncological Disorders in Rest of the World, till 2035 (USD Billion)
Figure 14.81 Medical Device CROs Market for Bone Disorders in Rest of the World, till 2035 (USD Billion)
Figure 14.82 Medical Device CROs Market for Respiratory Disorders in Rest of the World, till 2035 (USD Billion)
Figure 14.83 Medical Device CROs Market for Pain Disorders in Rest of the World, till 2035 (USD Billion)
Figure 14.84 Medical Device CROs Market for Ophthalmic Disorders in Rest of the World, till 2035 (USD Billion)
Figure 14.85 Medical Device CROs Market for Psychological Disorders in Rest of the World, till 2035 (USD Billion)
Figure 14.86 Medical Device CROs Market for Metabolic Disorders in Rest of the World, till 2035 (USD Billion)
Figure 14.87 Medical Device CROs Market for Other Disorders in Rest of the World, till 2035 (USD Billion)
Figure 14.88 Medical Device CROs Market for Class I Devices in Rest of the World, till 2035 (USD Billion)
Figure 14.89 Medical Device CROs Market for Class II Devices in Rest of the World, till 2035 (USD Billion)
Figure 14.90 Medical Device CROs Market for Class III Devices in Rest of the World, till 2035 (USD Billion)
Figure 14.91 Medical Device CROs Market for Clinical Trial Management Services in Rest of the World, till 2035 (USD Billion)
Figure 14.92 Medical Device CROs Market for Consulting Services in Rest of the World, till 2035 (USD Billion)
Figure 14.93 Medical Device CROs Market for Data Management Services in Rest of the World, till 2035 (USD Billion)
Figure 14.94 Medical Device CROs Market for Regulatory Affairs Management Services in Rest of the World, till 2035 (USD Billion)
Figure 14.95 Medical Device CROs Market for Other Clinical Services in Rest of the World, till 2035 (USD Billion)
Figure 14.96 Medical Device CROs Market for Material Characterization and Analytical Services in Rest of the World, till 2035 (USD Billion)
Figure 14.97 Medical Device CROs Market for Biocompatibility Testing Services in Rest of the World, till 2035 (USD Billion)
Figure 14.98 Medical Device CROs Market for Sterility and Microbiology Testing Services in Rest of the World, till 2035 (USD Billion)
Figure 14.99 Medical Device CROs Market for Other Preclinical Services in Rest of the World, till 2035 (USD Billion)
Figure 15.1 Medical Device CROs Market: SWOT Analysis
Figure 15.2 Comparison of SWOT Factors: Harvey Ball Analysis
Figure 16.1Future Trends and Opportunities for Medical Device CROs
Figure 17.1 Concluding Remarks: Overall Market Landscape
Figure 17.2 Concluding Remarks: Competitive Benchmarking
Figure 17.3 Concluding Remarks: Brand Positioning Analysis
Figure 17.4 Concluding Remarks: Clinical Trial Analysis
Figure 17.5 Concluding Remarks: Merger and Acquisitions
Figure 17.6 Concluding Remarks: Market Sizing and Opportunity Analysis (I/II)
Figure 17.7 Concluding Remarks: Market Sizing and Opportunity Analysis (II/II)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 1MED
  • 4Clinics
  • 4Pharma
  • A+ Science
  • Abiogenesis Clinpharm
  • Abond CRO
  • Absorption Systems
  • Absorption Systems
  • ABX-CRO
  • Acceliant
  • Accell Clinical Research
  • AccelLAB
  • Accelovance
  • Accredited Consultants
  • AccuLab Life Sciences
  • Accuprec Research Labs
  • Accutest Research Laboratories
  • Acorn Regulatory
  • Acrapack
  • acromion
  • aCROss Medical
  • ACT FARMA CRO
  • Activa Cro
  • ADAX International
  • Advanced Drug Development Services
  • Advanced Medical Research
  • Advena
  • Affinity Bio Partners
  • Afortiori Development
  • Afra Pharma Consultant
  • Aginko Research
  • AICROS
  • CETERA
  • AIX Scientifics
  • AJW Technology Consultants
  • ÅKRN
  • Al Tamimi & Company
  • Alera Labs
  • Alira Health
  • Allied Clinical Management
  • Altair Clinical
  • Altasciences
  • Altiora
  • AlvaMed
  • Amarex
  • American Preclinical Services (Acquired by NAMSA)
  • AmeRuss Clinical Trials
  • Amritt
  • AMS
  • Amulet Capital Partners
  • Anagram
  • analyze & realize
  • Andaman Medical
  • Anteris Medical
  • Antrix
  • Aperio
  • A-Pharma
  • A-pharmaconsult
  • apices
  • Appletree CI Group
  • Applied Clinical Services
  • Applied Healthcare Research Management
  • Aragen Life Sciences
  • Arazy Group Consultants
  • Archemin
  • Archer Research
  • ArchiMed
  • ARIRDMSCRO
  • ARQon
  • Asia Actual
  • Asiatic Clinical Research
  • ATLANSTAT
  • AtoZ-CRO
  • Auriga Research
  • Australian Healthcare Solutions
  • Auxilife Scientific Services
  • Avania
  • AVANTI
  • AVIAD Life Sciences
  • AXIS Clinicals
  • Axonal-Biostatem
  • Azelix
  • Baláti
  • Barons Medical Consulting
  • Beaufort
  • BECRO
  • Beijing JRJ Science and Technology
  • BIC Group
  • BioAgile Therapeutics
  • BioClever
  • Biocodex
  • Biomapas
  • Biomedical Regulatory Consulting
  • BioMedical Strategy
  • Bioneeds
  • BioPharma
  • BioPlan Associates
  • Biorasi
  • BIOREG Services
  • Biostat International
  • Biotech Regulatory Solutions
  • BioTecNiKa
  • BiTrial Clinical Research
  • BLAU Pharmaceutical Service
  • BLS laboratories
  • Boston Biomedical Associates
  • Boston MedTech Advisors
  • Brandwood CKC
  • Bridge Pharm
  • BRIDGE PTS
  • Bright Pharmaceutical Services
  • BRIGHT Research Partners
  • BSI Life Sciences
  • C&R Research
  • Cactus Global
  • Cairo University
  • Cara Therapeutics
  • Cardialysis
  • Cardinal Health
  • CardioMed Device Consultants
  • Cardiovascular European Research Center (CERC)
  • CARE Research
  • Caritas Clinical
  • Carpathian Research Group
  • CARSL Consulting
  • Catalyst Regulatory Services
  • Catawba Research
  • Cato Research
  • CBSET
  • CC Clinical research Consultants
  • CCS Associates (CCSA)
  • CERES
  • Charles River Laboratories
  • Chemical Inspection and Regulation Service
  • Chiasma
  • Chiltern
  • China Med Device
  • Citoxlab
  • Clarivate Analytics
  • CLINACT
  • ClinActis
  • ClinAudits
  • ClinChoice
  • ClinDatrix
  • Clinical Consulting
  • Clinical Device Group
  • Clinical Research & Compliance Consulting
  • Clinical Service Center
  • Clinical Trial Data Services
  • CliniExperts
  • Clinilabs Drug Development
  • Clinipace
  • CliniQAl™ International
  • CliniRx
  • Clinitude
  • Clinius
  • Clinlogix
  • Clinmark
  • Clinnex
  • ClinPro Research
  • Clinscience
  • ClinSearch
  • ClinSync
  • Clintec, an IQVIA Company
  • ClinVigilant
  • Cmed
  • CMIC Group
  • CMX Research
  • Cobridge
  • Cohortias
  • Commercial Eyes
  • Compliance Acuity
  • Concentrics Research
  • CONET
  • Consultys
  • Convex
  • Coronis Health
  • Costello Medical
  • Courante Oncology
  • Covance
  • CPS Cortex
  • CR Medicon
  • Criterium
  • CRO Pharmatrendz
  • Contract Research Organization for Medical Devices & Services (CROMDS)
  • Cromos Pharma
  • CROMSOURCE
  • CROS
  • CROs NT
  • Crown CRO
  • CRS Clinical Research Services
  • CSSi LifeSciences
  • CTC North
  • CTI
  • CTNT
  • CurAccel
  • Cvigilance
  • CW Research & Management
  • CYA Medical Device Consulting
  • Dalia Givony, Regulatory & Clinical Consulting
  • Databean
  • Datapharm Australia
  • De Groot Technical Services
  • DEKRA
  • Denothex
  • Devicia
  • Dexcom
  • DH RegSys
  • dicentra
  • DKSH Marketing Services Spain
  • dMed
  • Donawa Lifescience Consulting
  • Dor Pharmaceutical Services
  • Dove Quality Solutions
  • DP Clinical
  • Dr. Notghi Contract Research
  • DreamCIS
  • Drug Development and Regulation
  • DSA Consultants
  • DZS Clinical Services
  • EAS Consulting Group
  • East BS Clinical Research
  • ECLEVAR MEDTECH
  • ECSOR
  • Edwards Lifesciences
  • Egmont Group
  • Element
  • Emergent Clinical Consulting
  • Emergo
  • Emmes
  • En Pointe Clinical Research
  • Engel, Hellyer & Partners
  • e-novex
  • Envigo
  • EPIC Research
  • EPS International
  • EskeGen
  • ESTERN Medical
  • ETAP-Lab
  • ethica CRO
  • Ethicare Remedies
  • EuDRAcon
  • Eupraxia
  • Euraxi
  • Eurofins Medical Device Testing
  • The European Bioinformatics Institute (EMBL-EBI)
  • Europital
  • Everest Clinical Research
  • Evidilya
  • Exalon
  • Excelya
  • eXcorLab
  • Exom
  • Experior
  • ExperTrials
  • Farzan Clinical Research
  • FDAInsight
  • FGK Clinical Research
  • Firma Clinical Research
  • Five Corners
  • Focal Point Research
  • Formac Pharmaceuticals
  • Frestedt
  • Freyr
  • Gateway
  • GCP-Service International
  • genae
  • Genco Medical
  • Genelife Clinical Research
  • GenesisCare Clinical
  • GENOTRIX
  • Genpact
  • George Clinical
  • Getz Healthcare
  • GKM Medical Device Group
  • Global Center for Medical Innovation
  • Global Pharma Tek
  • Global Regulatory Affairs
  • Global Regulatory Partners
  • Global Regulatory Services
  • GLyPharma
  • GlyTech
  • GMED
  • Greenlight Clinical
  • Grove Group
  • Gsap
  • Hangzhou Tigermed Consulting
  • Harmony Clinical Research
  • Hart Clinical Consultants
  • Health Decisions
  • Healthcare International Partners
  • HealthCore
  • HealthLink
  • Highthink
  • Hilbert Paradox
  • HingeClinica
  • Honeywell
  • HungaroTrial
  • i3 Consulting
  • IBEX Preclinical Research
  • ICBio
  • ICCR-Roßdorf
  • ICON
  • ICRC-Weyer
  • ICTA
  • IDConic
  • Illingworth Research Group
  • ILS
  • IMARC
  • Inamed
  • Innomar Strategies
  • Innovo Medical
  • Inotiv
  • Inrextest
  • InSightec
  • Integrated Resources
  • Integrium
  • Intellim
  • International Drug Development Institute
  • International HealthCare
  • Intertek
  • INTOX
  • Ipsum
  • IQVIA
  • Iris Pharma
  • Ironstone Product Development
  • IRW
  • ISA HEALTH
  • Iuvo
  • IVD Consultants
  • IVDeology
  • IZiel Healthcare
  • Knipper Health
  • Japan MDC (JMDC)
  • JERELO
  • Johns Hopkins University
  • JSS Medical Research
  • Jyton
  • Kangan Pharmaceutical Consulting
  • KCR
  • KCRI
  • KD&A
  • Ken Block Consulting
  • Dentons Kensington Swan
  • Keystone Regulatory Services
  • KLIFO
  • Knoell
  • Kobridge Consulting
  • KPS Clinical Services
  • Krescent Medical Research
  • L.S. Marketing & Registration
  • L3 Healthcare
  • LabCorp
  • Lahav
  • Lambda Therapeutic Research
  • Larix
  • Lean RAQA
  • Leon Research
  • Likak Research
  • Li-Med
  • Linical Americas
  • LINK Medical
  • LIONBRIDGE
  • Liveon Biolabs
  • LNAge
  • Macnair Consultants
  • Made Consulting
  • MakroCare
  • Malca Chen-Zion Group
  • MANDALA International
  • Marti Farm
  • Massachusetts General Hospital
  • MasterControl
  • MAXIS
  • Mayo Clinic
  • McCarthy Consultant Services
  • MD Pharma Consulting
  • MD101Consulting
  • MD-Clinicals
  • mdi Europa
  • MDP-Solutions
  • MED Institute
  • Medanex Clinic
  • Medelis
  • Medfiles
  • Medical Equipment Compliance Associates
  • Medical Trials Analysis
  • Mediclin Clinical Research
  • Medicomp
  • Mediconomics
  • MEDICRO
  • MedicSense
  • Medidee
  • MEDIKAPOLI
  • MediqTrans
  • MEDITRIAL
  • MedNet
  • Medpace
  • MedPass International
  • MedQ Consultants
  • MedTech Impact Partners
  • MedTrials
  • Medtronic
  • MedVigil
  • Medvinbio Labs
  • Mene Research
  • Mericon
  • Meshayu Consultants
  • MethodSense
  • Metrics Research
  • Metronomia
  • MIC Medical
  • Micren Healthcare
  • Mid-Link Consulting
  • MileStone Research
  • MMS
  • Mn Solutions
  • Mobius Medical
  • MonitorCRO
  • Morley Research Consortium
  • Morula HealthTech
  • MPI Research
  • Mprex Healthcare
  • Musculoskeletal Clinical Regulatory Advisers
  • NAMSA
  • National Cancer Institute
  • National Institute of Mental Health
  • Navitas Life Sciences
  • NCGS
  • Nelson Labs
  • Neomed
  • Neometrix Consulting
  • Neopharm
  • Neox
  • Neozene
  • Nerac
  • Noble Life Sciences
  • Northlane Capital Partners
  • Norwich Clinical Research Associates
  • NovaTrials
  • Novem Healthcare
  • Novocure
  • Novum
  • NoyMed
  • NSF International
  • Nuvisan Pharma Services
  • Nyprax Pharma
  • O4 Research
  • Obelis Group
  • Odelle Technology
  • Onorach
  • Opera
  • Operon Strategist
  • OPIS
  • Optimal Pharm/Tox Consulting
  • Optimal Research
  • Optimapharm
  • Ora
  • Osmunda
  • OThree Consulting
  • Pace
  • Pacific BioLabs
  • Pacific Bridge Medical
  • Pacific Clinical Research Group
  • Pamplona Capital Management
  • Paradigm Research
  • PAREXEL
  • PaxMed
  • PCT Lab Research
  • PDC Healthcare
  • Peachtree BioResearch
  • Pearl Pathways
  • Pepgra
  • Perfect Pharmaceuticals Consultants
  • Perfection-CRO
  • Pfarrell Medical
  • Pharma To Market
  • Pharmaco-Kinesis
  • Pharmahungary Group
  • PharmaLex
  • Pharmalog
  • PharmaMed Research
  • Pharmaron
  • Pharmaseed
  • PharmaSols
  • Pharmaspecific
  • PharmDedict
  • PharmEng Technology
  • Pharm-Olam
  • PharmOut
  • Phidea Group
  • Pilgrim Quality Solutions
  • Pine Lake Laboratories
  • Pivotal
  • PMI Preclinical
  • PPD
  • PQE Group
  • PRA Health Sciences
  • PRADO
  • PRC Clinical
  • Preclinical Medevice Innovations
  • PreClinical Pathfinder
  • Pre-Clinical Research Services
  • Premier Research
  • Primacyt
  • proDERM
  • Regulatory Affairs Professionals Society
  • Profil
  • ProMedica
  • ProMedoss
  • PROMETRIKA
  • ProPharma Group
  • ProRelix Research
  • ProSciento
  • Prosoft Clinical
  • ProtoMed
  • ProTrials
  • Proxima Clinical Research
  • Pharmaceutical and Regulatory Services
  • Q&R Canada
  • QA Consulting
  • QAdvis
  • Qmed Consulting
  • QPS
  • Qserve Group
  • Q-Trials
  • QUADRO CRO
  • Qualitiso
  • Quality and Compliance Consulting
  • Qualtech
  • Quanticate
  • QUNIQUE
  • QVigilance
  • R & C Consulting
  • R&G PharmaStudies
  • RAHE Life Science
  • RAMED
  • Ratos
  • RAY
  • RCQ Solutions
  • RCRI
  • RCTs
  • Reg-Affairs & QualiPractixis
  • RegDesk
  • Registrar Corp
  • Regulatory Compliance Associates
  • Regulatory Insight
  • Reimbursement Strategies
  • Reliance Life Sciences
  • Research Professionals
  • Rho
  • RJR Consulting
  • Rocketpharm
  • Rook Quality Systems
  • Rotrial Contract Research
  • RQM+
  • RQMIS
  • RQSolutions
  • RTI Health Solutions
  • Scandinavian CRO
  • Scandinavian Regulatory Services
  • SCiAN Services
  • SCIderm
  • SCIRENT
  • Scope International
  • SDC
  • SeerPharma
  • Sentez CRO
  • Seoul CRO
  • SEQ
  • SGS
  • Shanghai QiSheng Business Consulting
  • Shenzhen Advanced Medical Services
  • Sidley Austin
  • Simmons & Simmons
  • SIPRA LABS
  • SIRO Clinpharm
  • Siron Clinical
  • Sixmurs Group
  • SLF
  • Smerud Medical Research
  • Smith+Nephew
  • SMS-Oncology
  • Sourcia
  • Southern Star Research
  • SPARTA
  • Specipig
  • Spectrum Clinical Research
  • SPharm
  • SPRIM Advanced Life Sciences
  • SRD
  • SRG Healthcare
  • Stanford University
  • StarFish Medical
  • Stat One
  • STATKING Clinical Services
  • Steinberg Research Solutions
  • SteriPack Group
  • SterlingBio
  • Strategic Compliance International
  • StrugoPharm
  • Sumika Chemical Analysis Service
  • SunFlare
  • Surpass
  • Surpass-Silicon Valley
  • Symbio
  • Symbion Research
  • Syncorp Health
  • Syneos Health
  • Syntactx
  • Syntax
  • Synteract
  • Syreon
  • Szasz&Co.
  • TAB Clinical
  • Target Health
  • TCA Clinical Research
  • Technical Resources International
  • TechnoSTAT
  • TentaMedix
  • TFS HealthScience
  • The Clinical Trial Company
  • The CRO Group
  • The Medical Affairs Company
  • Thema Med
  • Theo Manufacturing
  • Theorem Clinical Research
  • TheraGenesis
  • Therapeutics
  • Think Research
  • Tigermed
  • Toolbox
  • Toxikon
  • TransPerfect Life Sciences
  • Trial Form Support International
  • Trial Runners
  • Triangle Research Solutions
  • TriMetis
  • Turacoz Healthcare Solutions
  • TÜV SÜD-Healthcare & Medical Devices
  • Underwriters Laboratory
  • Unikal Consultants
  • University of California
  • VA Office of Research and Development
  • Valliscor
  • Vantage BioTrials
  • Vastrax
  • Veeda Clinical Research
  • Venn Life Sciences
  • Veristat
  • VIMTA
  • Visioncare Research
  • vivo Science (a Texcell acquired company)
  • Vivotecnia
  • VOLER Biotech Consulting
  • Vyomus Consulting
  • WCCT Global
  • WCG ThreeWire
  • WDB Holdings
  • Winicker Norimed
  • Wipro
  • Wonderville
  • Woodley BioReg
  • Worldwide Clinical Trials
  • WuXi AppTec
  • Zi-Medical
  • Zimmer Biomet
  • Zwiers Regulatory Consultancy

Methodology

 

 

Loading
LOADING...

Related Topics

Related Reports

Cell and Gene Therapy CRO Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Cell Therapy, Type of Genetic Modification, Stage of Development, Therapeutic Area, End-users and Key Geographical Regions - Product Image

Cell and Gene Therapy CRO Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Cell Therapy, Type of Genetic Modification, Stage of Development, Therapeutic Area, End-users and Key Geographical Regions

  • Report
  • 343 Pages
  • Global
From
Specialty CROs Market Industry Trends and Global Forecasts to 2035 - Distribution by Target Therapeutic Area, Type of Service and Key Geographical Regions - Product Image

Specialty CROs Market Industry Trends and Global Forecasts to 2035 - Distribution by Target Therapeutic Area, Type of Service and Key Geographical Regions

  • Report
  • 321 Pages
  • Global
From
Contract Research Organization (CRO) Services Market by Type (Early Phase, Clinical, Lab, Consulting), Therapeutic Area (Cancer (Breast, Lung), Infectious, Neurology, Vaccines), Modality (Small Molecules, Biologics, Biosimilars) - Global Forecast to 2030 - Product Image

Contract Research Organization (CRO) Services Market by Type (Early Phase, Clinical, Lab, Consulting), Therapeutic Area (Cancer (Breast, Lung), Infectious, Neurology, Vaccines), Modality (Small Molecules, Biologics, Biosimilars) - Global Forecast to 2030

  • Report
  • 634 Pages
  • Global
From
Medical Device Contract Research Organization (CRO) Market Report 2025 - Product Image

Medical Device Contract Research Organization (CRO) Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Preclinical CRO Market Size, Share, Trends, and Forecast by Service, End Use, and Region, 2025-2033 - Product Image

Preclinical CRO Market Size, Share, Trends, and Forecast by Service, End Use, and Region, 2025-2033

  • Report
  • 141 Pages
  • Global
From

About the Market

The Medical Device Contract Research Organization (CRO) market is a specialized segment of the medical device industry. It provides services to medical device companies, such as clinical trials, regulatory affairs, and product development. Medical device CROs are typically hired to help medical device companies bring their products to market faster and more efficiently. They provide expertise in areas such as clinical trial design, regulatory compliance, and product development. Medical device CROs are an important part of the medical device industry, as they provide the necessary expertise and resources to help medical device companies bring their products to market. They are also a key part of the medical device industry’s supply chain, as they provide the necessary services to ensure that medical devices are safe and effective. Some of the companies in the Medical Device CRO market include Parexel, ICON, PPD, Covance, and Syneos Health. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.